MannKind Corp. (MNKD)
5.63
-0.11
(-1.92%)
USD |
NASDAQ |
Feb 12, 16:00
5.60
-0.03
(-0.53%)
After-Hours: 20:00
MannKind Cash from Investing (Quarterly) : -25.06M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -1.299M |
| Keros Therapeutics, Inc. | -0.132M |
| BioMarin Pharmaceutical, Inc. | -330.96M |
| Ionis Pharmaceuticals, Inc. | 91.34M |
| Vertex Pharmaceuticals, Inc. | -117.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 23.49M |
| Cash from Financing (Quarterly) | 71.96M |
| Free Cash Flow | 42.74M |
| Free Cash Flow Per Share (Quarterly) | 0.0718 |
| Free Cash Flow to Equity (Quarterly) | -50.52M |
| Free Cash Flow to Firm (Quarterly) | 29.89M |
| Free Cash Flow Yield | 2.46% |